Showing results (31-40 of 356) with videos related to

Sort By:
Pageof 36
Biological Chemistry|May 28, 2016
Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCCMaria Stella Ritorto, Heidrun Rhode, Arndt Vogel, et al.
Der Pathologe|May 6, 2021
[BRAF-V600E testing in metastatic colorectal cancer and new, chemotherapy-free therapy options. German version]Michael Hummel, Susanna Hegewisch-Becker, Jens Neumann, et al.
Targeted Oncology|February 27, 2019
The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and ImmunotherapiesJens U Marquardt, Anna Saborowski, Carolin Czauderna, et al.
In Vivo (Athens, Greece)|November 16, 2014
First-line nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer from routine clinical practiceArndt Vogel, Uwe Pelzer, Al-Batran Salah-Eddin, et al.
Deutsches Arzteblatt International|November 22, 2014
The diagnosis and treatment of cholangiocarcinomaArndt Vogel, Henning Wege, Karel Caca, et al.
Lancet (London, England)|September 9, 2022
Hepatocellular carcinomaArndt Vogel, Tim Meyer, Gonzalo Sapisochin, et al.
Journal of Gastroenterology and Hepatology|December 11, 2002
Autoimmune hepatitis and overlap syndromesArndt Vogel, Heiner Wedemeyer, Michael P Manns, et al.
Therapeutic Advances in Medical Oncology|April 3, 2023
Adjuvant therapy of biliary tract cancersJoanna Kefas, John Bridgewater, Arndt Vogel, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonistsAlexander Stein, Markus Moehler, Jörg Trojan, et al.
Expert Review of Gastroenterology & Hepatology|May 5, 2025
The clinical implications of trial endpoints in immunotherapy for hepatocellular carcinomaXun Zhao, Talia Dufault, Gonzalo Sapisochin, et al.
Pageof 36